help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 4, 2004
Molecular Endocrinology, doi:10.1210/me.2004-0312
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/3/812    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jorgensen, R.
Right arrow Articles by Elling, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jorgensen, R.
Right arrow Articles by Elling, C. E.

Submitted on August 4, 2004
Accepted on October 28, 2004

Characterization of Glucagon-Like Peptide-1 Receptor {beta}arrestin2 Interaction: A high Affinity Receptor Phenotype

Rasmus Jorgensen, Lene Martini, Thue W. Schwartz, and Christian E. Elling*

7TM Pharma A/S, Fremtidsvej 3, DK-2970 Horsholm, Denmark; Laboratory for Molecular Pharmacology, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2100, Denmark

* To whom correspondence should be addressed. E-mail: cee{at}7tm.com.

To dissect the interaction between {beta}arrestin and family B G-protein coupled receptors, we constructed fusion proteins between the Glucagon Like Peptide-1 receptor and {beta}arrestin2. The fusion constructs had an increase in apparent affinity selectively for glucagon suggesting that {beta}arrestin2 interaction locks the receptor in a high affinity conformation, which can be explored by some but not all ligands. The fusion constructs adopted a signaling phenotype governed by the tethered {beta}arrestin2 with an attenuated G-protein mediated cAMP signal and a higher maximal internalization compared with wild type receptors. This distinct phenotype of the fusion proteins can not be mimicked by co-expressing wild type receptor with {beta}arrestin2. However, when the wild type receptor was co-expressed with both {beta}arrestin2 and G-protein coupled receptor kinase 5, a phenotype similar to that observed for the fusion constructs was observed. We conclude that the GLP-1 fusion construct mimics the natural interaction of the receptor with {beta}arrestin2 with respect to binding peptide ligands, G-protein mediated signaling and internalization, and that this distinct molecular phenotype is reminiscent of that which has previously been characterized for family A G-protein coupled receptors suggesting similarities in the effect of {beta}arrestin interaction between family A and -B receptors also at the molecular level.


Key words: Glucagon-like peptide-1 receptor • G-protein coupled receptor • 7TM receptor • family B • {beta}arrestin • BRET • G-protein coupled receptor kinase




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B. W. Jones and P. M. Hinkle
Arrestin Binds to Different Phosphorylated Regions of the Thyrotropin-Releasing Hormone Receptor with Distinct Functional Consequences
Mol. Pharmacol., July 1, 2008; 74(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. D. Holliday, B. Holst, E. A. Rodionova, T. W. Schwartz, and H. M. Cox
Importance of Constitutive Activity and Arrestin-Independent Mechanisms for Intracellular Trafficking of the Ghrelin Receptor
Mol. Endocrinol., December 1, 2007; 21(12): 3100 - 3112.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling
Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha}
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
L. Elster, C. Elling, and A. Heding
Bioluminescence Resonance Energy Transfer as a Screening Assay: Focus on Partial and Inverse Agonism
J Biomol Screen, February 1, 2007; 12(1): 41 - 49.
[Abstract] [PDF]


Home page
EndocrinologyHome page
B. Holst, K. L. Egerod, E. Schild, S. P. Vickers, S. Cheetham, L.-O. Gerlach, L. Storjohann, C. E. Stidsen, R. Jones, A. G. Beck-Sickinger, et al.
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
Endocrinology, January 1, 2007; 148(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society